Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital, discusses treatment approaches for atopic dermatitis of the face in infancy, which he presented at the Revolutionizing Atopic Dermatitis conference.
This session's talk is the first time anyone has ever delved deep into looking at atopic dermatitis in infancy, specifically of the face, says Robert Sidbury, MD, MPH, professor of pediatrics at Seattle Children's Hospital.
Transcript
Can you describe the highlights of your presentation on treating infant atopic dermatitis?
I specifically talked about treating the face in infancy, which is, as I mentioned in the talk, the first time anyone has ever carved out that particular topic in a session. That's kudos to Dr Silverberg for realizing that that—as I called it in this session— is the "original sin of atopic dermatitis," as most patients with atopic dermatitis develop it in childhood.
Most patients who develop atopic dermatitis in childhood, it starts, as an infant, on the face. And so, it's really important because not only is that sort of the "original sin," as I called it, it's also a place where pediatricians and parents, and oftentimes dermatologists, are reluctant to treat because it's a baby, it's around the eyes, it's close to the mouth, they might ingest something you put on their face. So, there are a lot of reasons why it's an important area to try to learn more about.
What is the most effective approach to managing and treating atopic dermatitis in infants?
It starts with nothing pharmaceutical at all, because a lot of times infants have irritant contact dermatitis; you biopsy it, it's identical to atopic dermatitis. It is eczema in a sense; it's rash, it itches, it's red, it's inflamed, it can get infected. All of these things are true, but sometimes it's primarily due just to the frequent wetting and drying that is part and parcel of being an infant, where a good percentage of the food goes on the face and not in the mouth. And then there's cleaning with potentially harsh wipes and things of that nature, which can make that area quite a challenge.
One of the first things that I always want to make sure parents realize is that, and therefore, try to mitigate it by simple things like putting barriers around the mouth before they feed. A petrolatum base, something relatively thick, around the mouth and the chin and the chest where the bib gets saturated. Wet, dry, wet, dry, the enemy of eczema. Put that barrier around the mouth before the meal, they feed, they get messy, after the meal you clean them up, put another barrier, they're good to go!
It's not a medicine, parents are very comfortable with it. They just need to realize that that's part of the problem, that sort of wet, dry, wet, dry, that sometimes something so simple can mitigate.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Overcoming Employment Barriers for Lasting Social Impact: Freedom House 2.0 and Pathways to Work
April 16th 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. Welcome to our second episode, in which we learn all about Freedom House 2.0 and the Pathways to Work program.
Listen
Standard Criteria for Loss of Ambulation Needed in DMD
April 19th 2024A recent study suggests the differences between ambulation definitions for patients with Duchenne muscular dystrophy (DMD) can impact the identification of ambulant vs nonambulant individuals, and standard criteria across settings are needed.
Read More